Related Experiment Videos
[Drug therapy in sensorineural hearing loss in childhood]
A Nickisch1, M Heinemann, M Gross
1Klinik für Kommunikationsstörungen, Johannes-Gutenberg-Universität, Mainz.
Laryngologie, Rhinologie, Otologie
|December 1, 1987
Insights
This study treated 40 children with progressive sensorineural hearing loss using prednisolone and pentoxifylline. Over half showed improved hearing thresholds, suggesting a potential treatment benefit.
Area of Science:
- Otolaryngology
- Pharmacology
- Audiology
Context:
- Progressive sensorineural hearing loss (SNHL) in children presents significant audiological challenges.
- Current treatment options for pediatric SNHL are limited, necessitating exploration of novel therapeutic strategies.
- Understanding the etiology of SNHL is crucial for targeted interventions.
Purpose:
- To evaluate the efficacy of combined prednisolone and pentoxifylline infusions in treating pediatric progressive sensorineural hearing loss.
- To assess the impact of this therapeutic regimen on pure tone audiometric thresholds.
- To correlate treatment outcomes with underlying etiological factors of hearing loss.
Summary:
- Forty children diagnosed with progressive sensorineural hearing loss received intravenous infusions of prednisolone and pentoxifylline.
- Post-treatment audiometric evaluations revealed statistically significant improvements in auditory thresholds for 52.5% of the participants.
- The observed benefits were analyzed in conjunction with the specific etiological findings for each child.
Impact:
- This research suggests a potential therapeutic avenue for managing progressive sensorineural hearing loss in pediatric populations.
- The findings may inform clinical practice by highlighting the effectiveness of specific pharmacological interventions.
- Further investigation into the mechanisms and long-term effects is warranted to optimize treatment protocols.
Abstract:
40 children were treated for progressive sensorineural hearing loss with infusions of prednisolone and pentoxifylline. After this treatment pure tone audiometric findings showed improved auditory thresholds in 52.5%. The results are discussed dependent on aetiologic findings.